Production (Stage)
Mineralys Therapeutics, Inc.
MLYS
$16.12
$0.503.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.32% | -16.22% | 3.88% | 19.16% | 25.10% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 39.08% | -42.85% | -64.45% | -17.94% | 78.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.22% | -17.56% | 0.89% | 18.00% | 25.99% |
|
|
|||||
| Total Current Assets | 2.22% | -17.56% | 0.89% | 18.00% | 25.99% |
| Net Property, Plant & Equipment | -25.49% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.75% | 878.43% | 786.27% | 780.39% | 871.79% |
| Total Assets | 2.22% | -18.17% | -3.35% | 9.37% | 13.32% |
|
|
|||||
| Total Accounts Payable | -91.25% | -20.30% | -44.27% | -22.27% | 78.51% |
| Total Accrued Expenses | -12.92% | 43.38% | 254.02% | 565.42% | 258.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -30.30% | 39.73% | 131.27% | 357.50% | 81.86% |
|
|
|||||
| Total Current Liabilities | -30.30% | 39.73% | 131.27% | 357.50% | 81.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -30.30% | 39.73% | 131.27% | 357.50% | 81.86% |
|
|
|||||
| Common Stock & APIC | 41.72% | 34.96% | 34.63% | 34.41% | 34.04% |
| Retained Earnings | -120.67% | -142.58% | -152.77% | -154.30% | -138.80% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.12% | -20.69% | -10.26% | 1.78% | 10.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.12% | -20.69% | -10.26% | 1.78% | 10.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.12% | -20.69% | -10.26% | 1.78% | 10.87% |
|
|
|||||